Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds SVB Leerink Maintains Underperform on Incyte, Raises Price Target to $63

SVB Leerink Maintains Underperform on Incyte, Raises Price Target to $63

SVB Leerink analyst Andrew Berens maintains Incyte (NASDAQ:INCY) with a Underperform and raises the price target from $58 to $63.

July 20, 2022

1 minute read

SVB Leerink analyst Andrew Berens maintains Incyte (NASDAQ:INCY) with a Underperform and raises the price target from $58 to $63.

Meta Platforms, Snap And 3 Stocks To Watch Heading Into Wednesday

February 1, 5:05 AM

With US stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:

December 19, 12:30 PM

IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 10 years by 16.17% on an annualized basis…

June 2, 6:35 AM

Apple Inc. (NASDAQ:AAPL) launched its high-yield savings account in late April to great acclaim. However, recent reports suggest that the…

November 15, 3:45 PM

ChargePoint Holdings Inc (NYSE: CHPT) has launched the first large-scale deployment of its